How to Get
Brekiya autoinjector

Brekiya autoinjector is exclusively available through two specialty pharmacies

You may be eligible to pay as little as $40 per carton*,†

*Restrictions apply.

Brekiya autoinjector carton

Each carton contains 4 single-dose autoinjectors.1

HOW DO I GET MY PRESCRIPTION?

1

Your healthcare provider will submit your prescription to one of two specialty pharmacies, and that pharmacy will call or text you within 2 business days.

2

The specialty pharmacy will confirm your insurance coverage. If there are any questions, they will call or text you or your healthcare provider, as needed.

Some of the things they may need to confirm with you are:

3
The specialty pharmacy will mail your Brekiya autoinjector prescription to the shipping address you provided.

NEED SUPPORT?

If you have not received a phone call from the pharmacy within 48 hours after visiting your healthcare provider or have any questions about your medication, please contact the specialty pharmacy directly by phone.

Be sure to answer any text message or calls from your specialty pharmacy to get your prescription filled.

Sterling Specialty Pharmacy

Phone number: 888-618-4126

Walgreens Specialty Pharmacy

Phone number: 888-282-5166

Standard text messaging rates apply.

Eligible patients may be eligible for financial assistance for your Brekiya autoinjector prescription

Copay Program

If you have commercial insurance, you may pay as little as $40 per carton for your Brekiya autoinjector prescription. The specialty pharmacies will automatically enroll qualified, commercially-insured patients, no cards or coupons needed. Restrictions apply. Each carton contains 4 single-dose autoinjectors. Please see full terms, conditions, and eligibility criteria.

Explore helpful resources

Review the access and educational materials below to better support you.

Brekiya autoinjector resources

Consumer Brochure

Instructions for Use PDF

Instructions for Use Video

Support you can count on

Explore resources and community connections that can help empower and assist you every step of the way along your journey.

Clusterbusters
Clusterbusters§
Miles For Migraine
Miles for Migraine§
The Headache Alliance
The Headache Alliance§
Association Of Migraine Disorders®
Association for Migraine Disorders§
§Clicking Learn More will take you to a site owned and operated by an independent third party, to which the Privacy Policy does not apply. We do not review or control the content of external websites, and this does not constitute an endorsement of any other site’s content.

NEXT PAGE >

IMPORTANT SAFETY INFORMATION

Expand

Collapse

Chevron icon

Serious or potentially life-threatening reductions in blood flow to the brain or extremities due to interactions between dihydroergotamine (the active ingredient in Brekiya autoinjector) with strong CYP3A4 inhibitors (such as protease inhibitors and macrolide antibiotics) have been reported rarely. As a result, these medications should not be taken together.

Do not use Brekiya autoinjector if you:

  • are taking medicines known as strong CYP3A4 inhibitors, such as: ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, ketoconazole, or itraconazole.
  • have heart problems or a history of heart problems, or uncontrolled high blood pressure.
  • have narrowing of blood vessels in your legs, arms, stomach, or kidneys (peripheral vascular disease).
  • have sepsis, had vascular surgery, severe liver or kidney problems.
  • are allergic to dihydroergotamine, ergot alkaloids, latex, or any of the ingredients in Brekiya autoinjector.
  • have taken any of the following medicines in the last 24 hours: sumatriptan, frovatriptan, ergotamine or ergotamine-type medicines, almotriptan, naratriptan, zolmitriptan, eletriptan, or rizatriptan
  • have taken any medicines that constrict your blood vessels or raise your blood pressure.
Before you take Brekiya autoinjector, tell your healthcare provider about all your medical conditions, including if you:
  • have high blood pressure, liver problems, or kidney problems.
  • have risk factors for heart disease, such as: high blood pressure, high cholesterol levels, smoke, are overweight, diabetes, family history of heart disease.
  • are pregnant or plan to become pregnant. Brekiya autoinjector may cause preterm labor. Brekiya autoinjector should be avoided during pregnancy. Talk to your healthcare provider right away if you are pregnant or want to become pregnant.
  • are breastfeeding or plan to breastfeed. Brekiya autoinjector may reduce breast milk supply and pass into your breast milk. Brekiya autoinjector may be harmful to your baby. Do not breastfeed your baby while taking Brekiya autoinjector and for 3 days after you use Brekiya autoinjector. Talk with your healthcare provider about the best way to feed your baby if you take Brekiya autoinjector.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take: sumatriptan, ergot-type medicine, saquinavir, nefazodone, fluconazole, grapefruit juice, zileuton, nicotine, propranolol or other medicines that can lower your heart rate, any medicines that can increase your blood pressure, selective serotonin reuptake inhibitors. These are not all of the medicines that could affect how Brekiya autoinjector works. Your healthcare provider can tell you if it is safe to take Brekiya autoinjector with other medicines.

How should I use Brekiya autoinjector?

  • Certain people should take their first dose of Brekiya autoinjector in their healthcare provider’s office or in another medical setting.
  • Brekiya autoinjector is for injection under the skin (subcutaneous) only.
  • Use Brekiya autoinjector exactly as your healthcare provider tells you to use it.
  • Each autoinjector contains one dose (1 mg).
  • If your headache comes back after the first complete dose, you may give yourself up to 2 more doses as needed. Wait at least one hour between doses.
  • Do not inject more than 3 doses (3 mg) of Brekiya autoinjector in a 24‑hour period or 6 doses (6 mg) in a 1‑week (7 day) period.

What are the possible side effects of Brekiya autoinjector?
Brekiya autoinjector can cause serious side effects, including:

  • Heart attack and other heart problems. Heart problems may lead to death. Stop taking Brekiya autoinjector and get emergency medical help right away if you have any symptoms of a heart attack, such as: numbness or tingling in your fingers and toes, muscle pain or cramps in your arms and legs, weakness in your legs, temporary speeding or slowing of your heart rate, or swelling or itching. Brekiya autoinjector is not for people with risk factors for heart disease unless a heart exam is done and shows no problem.
  • Stroke. Stop using Brekiya autoinjector and get emergency medical help right away if you have any of the symptoms of a stroke.
  • Changes in color or sensation in your fingers and toes (Raynaud’s syndrome).
  • Stomach and intestinal problems.
  • Increased blood pressure.
  • Medicine overuse headache. Some people who use too much Brekiya autoinjector may make their headaches worse. If your headaches get worse, your healthcare provider may decide to stop your treatment with Brekiya autoinjector.
  • Preterm labor.
  • Tissue changes (fibrotic complications). Inflammation and fiber-like tissue that is not normal (fibrosis) can occur around the lungs and stomach.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all of the possible side effects of Brekiya autoinjector. Call your healthcare provider for medical advice about side effects.

How should I store Brekiya autoinjector?
  • Store at room temperature between 68°F to 77°F (20°C to 25°C). Do not refrigerate or freeze.
  • Protect Brekiya autoinjector from light.
  • Keep Brekiya autoinjector in the original pack until ready to use.
Indication
Brekiya autoinjector is a prescription medicine used for the acute treatment of migraine with or without aura and the acute treatment of cluster headaches in adults.

Brekiya autoinjector is not used to prevent migraine or used to treat other types of headaches such as hemiplegic migraines (that make you unable to move on one side of your body) or basilar migraines (rare form of migraine with aura). It is not known if Brekiya autoinjector is safe and effective in children.

To report SUSPECTED ADVERSE REACTIONS, contact Amneal Specialty, a division of Amneal Pharmaceuticals LLC at 1‑877‑835‑5472, or FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch.

Please see full Prescribing Information, including Boxed Warning, Medication Guide, and Instructions for Use.

References: 1. Brekiya [package insert]. Bridgewater, NJ: Amneal Pharmaceuticals LLC; 2025.

TERMS, CONDITIONS, AND ELIGIBILITY CRITERIA

  1. This card is not valid for prescriptions submitted for reimbursement to Medicare, Medicaid, Medigap, VA, DOD, or TriCare, or where prohibited by law; to other federal or state programs (including any state pharmaceutical assistance programs); or to private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. Patients may not use this card if Brekiya autoinjector is covered under their Medicare prescription drug plan or if they are Medicare-eligible and enrolled in an employer sponsored health plan or prescription drug benefit program for retirees.
  2. This card is good for use only with a Brekiya autoinjector prescription at the time the prescription is filled by the pharmacist and dispensed to the patient.
  3. This offer is good until the program expires.
  4. Maximum reimbursement limits apply; patient out-of-pocket expenses may vary.
  5. Amneal reserves the right to rescind, revoke, or amend this offer without notice.
  6. Offer good only in the US.
  7. Void if prohibited by law, taxed, or restricted.
  8. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law.

You are now leaving brekiya.com

You are now leaving

brekiya.com

You are now leaving this site. This link will take you to a different site that is owned and operated by an independent third party to which the Privacy Policy does not apply. We do not review or control the content of external websites and this hyperlink does not constitute an endorsement of any other site’s content. Do you want to continue?